Anti-GFRAL/ C6orf144/ GRAL monoclonal antibody

Anti-GFRAL/ C6orf144/ GRAL antibody for FACS & in-vivo assay

Target products collectionGo to GFRAL/GFRAL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T37012-Ab-1/ GM-Tg-hg-T37012-Ab-2Anti-Human GFRAL monoclonal antibodyHuman
GM-Tg-rg-T37012-Ab-1/ GM-Tg-rg-T37012-Ab-2Anti-Rat GFRAL monoclonal antibodyRat
GM-Tg-mg-T37012-Ab-1/ GM-Tg-mg-T37012-Ab-2Anti-Mouse GFRAL monoclonal antibodyMouse
GM-Tg-cynog-T37012-Ab-1/ GM-Tg-cynog-T37012-Ab-2Anti-Cynomolgus/ Rhesus macaque GFRAL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T37012-Ab-1/ GM-Tg-felg-T37012-Ab-2Anti-Feline GFRAL monoclonal antibodyFeline
GM-Tg-cang-T37012-Ab-1/ GM-Tg-cang-T37012-Ab-2Anti-Canine GFRAL monoclonal antibodyCanine
GM-Tg-bovg-T37012-Ab-1/ GM-Tg-bovg-T37012-Ab-2Anti-Bovine GFRAL monoclonal antibodyBovine
GM-Tg-equg-T37012-Ab-1/ GM-Tg-equg-T37012-Ab-2Anti-Equine GFRAL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T37012-Ab-1/ GM-Tg-hg-T37012-Ab-2; GM-Tg-rg-T37012-Ab-1/ GM-Tg-rg-T37012-Ab-2;
GM-Tg-mg-T37012-Ab-1/ GM-Tg-mg-T37012-Ab-2; GM-Tg-cynog-T37012-Ab-1/ GM-Tg-cynog-T37012-Ab-2;
GM-Tg-felg-T37012-Ab-1/ GM-Tg-felg-T37012-Ab-2; GM-Tg-cang-T37012-Ab-1/ GM-Tg-cang-T37012-Ab-2;
GM-Tg-bovg-T37012-Ab-1/ GM-Tg-bovg-T37012-Ab-2; GM-Tg-equg-T37012-Ab-1/ GM-Tg-equg-T37012-Ab-2
Products NameAnti-GFRAL monoclonal antibody
Formatmab
Target NameGFRAL
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GFRAL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GFRAL/ C6orf144/ GRAL VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T37012-Ag-1GDNF family receptor alpha like (GFRAL) protein
    ORF Viral VectorvGMLP001654human GFRAL Lentivirus particle
    ORF Viral VectorpGMLP001654human GFRAL Lentivirus plasmid
    ORF Viral VectorpGMLPm004307mouse Gfral Lentivirus plasmid
    ORF Viral VectorvGMLPm004307mouse Gfral Lentivirus particle


    Target information

    Target IDGM-T37012
    Target NameGFRAL
    Gene ID389400,404194,501023,714935,481851,101097066,531956,100069686
    Gene Symbol and SynonymsbA360D14.1,C6orf144,GFRAL,GRAL,RGD1565220,UNQ9356
    Uniprot AccessionQ6UXV0,D3ZB94
    Uniprot Entry NameGFRAL_HUMAN,GFRAL_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000187871
    Target ClassificationN/A

    The target: GFRAL, gene name: GFRAL, also named as C6orf144, GRAL, UNQ9356, bA360D14.1. Enables glial cell-derived neurotrophic factor receptor activity and receptor tyrosine kinase binding activity. Involved in glial cell-derived neurotrophic factor receptor signaling pathway; positive regulation of MAPK cascade; and positive regulation of protein kinase B signaling. Located in external side of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.